Selection of a Clinical Lead TCR Targeting Alpha-Fetoprotein-Positive Liver Cancer Based on a Balance of Risk and Benefit
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Selection of a Clinical Lead TCR Targeting Alpha-Fetoprotein-Positive Liver Cancer Based on a Balance of Risk and Benefit
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-04-27
DOI
10.3389/fimmu.2020.00623
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preclinical Studies of the Off-Target Reactivity of AFP158-Specific TCR Engineered T Cells
- (2020) Lun Cai et al. Frontiers in Immunology
- Safety and Tolerability of Adoptive Cell Therapy in Cancer
- (2019) Benita Wolf et al. DRUG SAFETY
- Treatment Lines in Hepatocellular Carcinoma
- (2019) Henning Wege et al. Visceral Medicine
- T cell engineering for adoptive T cell therapy: safety and receptor avidity
- (2019) Elvira D’Ippolito et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Biology and significance of alpha‐fetoprotein in hepatocellular carcinoma
- (2019) Peter R. Galle et al. LIVER INTERNATIONAL
- Clinical lessons learned from the first leg of the CAR T cell journey
- (2019) Robbie G. Majzner et al. NATURE MEDICINE
- Identification of α-fetoprotein-specific T-cell receptors for hepatocellular carcinoma immunotherapy
- (2018) Wei Zhu et al. HEPATOLOGY
- CAR T cell immunotherapy for human cancer
- (2018) Carl H. June et al. SCIENCE
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Tuning T cell receptor affinity to optimize clinical risk-benefit when targeting α-fetoprotein-positive liver cancer
- (2018) Roslin Y. Docta et al. HEPATOLOGY
- Prognostic value of tumor-infiltrating lymphocytes in hepatocellular carcinoma
- (2018) Wei Ding et al. MEDICINE
- The Prognostic Value of Tumor-infiltrating Lymphocytes in Hepatocellular Carcinoma: a Systematic Review and Meta-analysis
- (2017) Wei Yao et al. Scientific Reports
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Targeting Alpha-Fetoprotein (AFP)–MHC Complex with CAR T-Cell Therapy for Liver Cancer
- (2016) Hong Liu et al. CLINICAL CANCER RESEARCH
- Deep sequencing of the MHC region in the Chinese population contributes to studies of complex disease
- (2016) Fusheng Zhou et al. NATURE GENETICS
- Molecular basis for universal HLA-A*0201–restricted CD8+T-cell immunity against influenza viruses
- (2016) Sophie A. Valkenburg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Enhancing adoptive T cell immunotherapy with microRNA therapeutics
- (2016) Yun Ji et al. SEMINARS IN IMMUNOLOGY
- Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice
- (2015) Matthias Obenaus et al. NATURE BIOTECHNOLOGY
- Adoptive cell transfer as personalized immunotherapy for human cancer
- (2015) S. A. Rosenberg et al. SCIENCE
- Engineered cytotoxic T lymphocytes with AFP-specific TCR gene for adoptive immunotherapy in hepatocellular carcinoma
- (2015) Longhao Sun et al. TUMOR BIOLOGY
- Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations
- (2014) Faviel F. González-Galarza et al. NUCLEIC ACIDS RESEARCH
- Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy
- (2013) Richard A. Morgan et al. JOURNAL OF IMMUNOTHERAPY
- Identification of a Titin-Derived HLA-A1-Presented Peptide as a Cross-Reactive Target for Engineered MAGE A3-Directed T Cells
- (2013) B. J. Cameron et al. Science Translational Medicine
- Interplay between T Cell Receptor Binding Kinetics and the Level of Cognate Peptide Presented by Major Histocompatibility Complexes Governs CD8+T Cell Responsiveness
- (2012) Melita Irving et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis
- (2010) Maria R Parkhurst et al. MOLECULAR THERAPY
- Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen
- (2009) L. A. Johnson et al. BLOOD
- Public clonotype usage identifies protective Gag-specific CD8+T cell responses in SIV infection
- (2009) David A. Price et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IRF-1 and p65 mediate upregulation of constitutive HLA-A antigen expression by hepatocellular carcinoma cells
- (2009) Yuqing Shen et al. MOLECULAR IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More